Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
radiobiological mechanisms. By integrating radiopharmaceutical science, immunotherapy, and translational oncology, this project aims to develop a robust combination therapy platform for OC and TNBC which can help
-
the tumor immune microenvironment, with particular emphasis on macrophage-targeted immunotherapies and advanced preclinical models using cutting-edge technologies. The Research Associate will play a key role
-
University of California, San Francisco | San Francisco, California | United States | about 1 month ago
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte
-
University of California, San Francisco | San Francisco, California | United States | about 1 month ago
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte
-
University of California, San Francisco | San Francisco, California | United States | about 1 month ago
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte
-
The Yang Lab (https://medicine.osu.edu/find-faculty/non-clinical/molecular-medicine-and-therapeutics/liping-yang ) is recruiting a highly motivated and creative Research Scientist to join our new research
-
discover how we can advance health together. Duke Health Integrated Practice https://careers.dukehealth.org/us/en/dhip Duke Health Integrated Practice comprises more than 110 primary and specialty outpatient
-
excellence who investigate the fields of cancer immunology and immunotherapy, with the long-term goal of developing novel approaches for the treatment of cancer. Located in Boston and the surrounding
-
a proven commitment to advancing research in immunotherapies. The appointee is expected to (a) work closely with Prof. XIA Jiang’s research group (https://chem.cuhk.edu.hk/people/academic-staff/xj
-
with a strong background in cellular immunotherapies to match the scientific profile of the DKTK partner site Frankfurt/Mainz (https://dktk.dkfz.de/en/sites/frankfurt-mainz ) at the Mainz location